SAFE, PRIVATE & SECURE
Your iOPharma™ account is password protected and safe from prying eyes. All iOPharma™ plans include SSL security - the same as online banks. Your data is secure.
SUPPORT FOR MULTIPLE LANGUAGES
iOPharma™ will be translated into Chinese, Spanish, French, German and Portuguese. More languages will be added to this list as time goes on. To find out more about the translations, please contact us at info@io-pharma.com.
FREE REGISTRATION
Whether you’re a buyer or a supplier the iOPharma™ platform will benefit your organisation.
REGISTER NOW
Ranbaxy buy triggers Sun Pharma’s Zenotech offer
Sun Pharmaceutical Industries has made an open offer for Hyderabad-based firm Zenotech Laboratories.
Read moreRoche buy the rights to drug that’s meant to switch on genes blocking growth of cancer
The purchase gives Roche its first drug in human testing in the field of epigenetics.
Read moreJapan drugmaker Takeda to fight $6bn damages imposed by US jury
Takeda Pharmaceutical’s shares fell as much as 8.8 per cent to an eight-month low in Tokyo...
Read moreResearchers identify novel compound effective against drug-resistant lung cancer
Despite advances made in detecting and treating nonsmall cell lung cancer , its prognosis remains...
Read moreSun Pharma to buy Ranbaxy in a $4 bn deal; smart move, says Dr Reddy's G V Prasad
In what is being described by a landmark deal in Indian pharma, Sun Pharma and Ranbaxy on Monday...
Read moreTeam culturing cancer APIs says tech can make other plant derived drugs
Enzyme experts trying to make vincristine and vinblastine with engineered cell lines say the...
Read moreStudy Suggests Link Between Viagra And Melanoma
In recent years researchers have uncovered a potentially important pathway whereby PDE5A inhibitors...
Read moreScientists Rejuvenate Organ in Old Mice
U.K. scientists who used gene manipulation to rejuvenate a worn-out organ in older mice said their...
Read moreExperimental drug shows promise for treatment-resistant leukemias
Research in mice and human cell lines has identified an experimental compound dubbed TTT-3002 as...
Read moreSanten signs licence deal with Akorn for marketing of tafluprost in US
Japan-based Santen Pharmaceutical (Santen) has signed a licensing agreement with Oak...
Read more